Advanced Filters
noise
Found 63,122 clinical trials

A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF

The purpose of this phase 3 multicenter, double-blinded, placebo-controlled study in India is to learn about the safety and immunogenicity of RSVpreF in adults.

18 years of age All Phase 3
J Jennifer Nguyen

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

18 years of age All Phase N/A
A Abdul-Rahman Halabi

A Trial of CRD-4730 in HFrEF

CRD-4730 is a calcium/calmodulin-dependent protein kinase II (CaMKII) inhibitor. The CALIBRATE-HF trial is a Phase 2, global, multi-center, randomized, double-blind, parallel-group, placebo-controlled trial. The trial will evaluate the efficacy, safety, and tolerability of CRD-4730 in addition to guideline directed medical therapy in participants with heart failure with reduced ejection fraction …

18 - 85 years of age All Phase 2
P Prof. Dana Tzur-Bitan, Prof.

Mechanisms and Outcomes of Children and Adolescent Psychotherapy

Since October 7th 2023, Israel's population has been forced to engage in a multi-regional war which affected most of the citizens of Israel. One of the most sensitive populations to be affected by the horrifying events are children and adolescents. In a meta-analysis summarizing the results of 20 studies encompassing …

6 years of age All Phase N/A
C Cecilia Lund, MD, Phd.

Zinc Supplementation and Infections in Older Medical Patients

The goal of this clinical trial is to learn about the effect of zinc supplementation once daily for 12 months in older acute medical patients. The main question it aims to answer is: • Can daily zinc supplementation for 12 months increase Days Alive and Out of Hospital (DAOH)? Researchers …

65 years of age All Phase N/A
S Shugeng Gao, MD

A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China

This chart review study is proposed in China to understand the treatment patterns, biomarker testing, and clinical outcomes with SOC and some selected regimens among patients diagnosed with stage I-III NSCLC.

18 years of age All Phase N/A
C Cathy Cheney

PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study

This is a 16-week prospective, single-arm cohort, study of patients initiating advanced therapy for the treatment of moderate-to-severe plaque PSO. Eligible patients must be willing to be seen in-person by their treating physician for a Baseline visit (with first dose of the advanced therapy occurring within 14 days), and at …

18 years of age All Phase N/A
C Clayton Neighbors, Ph.D.

Evaluating Telehealth Delivery of Brief Alcohol Screening and Intervention for College Students

This research study will test the efficacy of a telehealth version of the Brief Alcohol Screening and Intervention for College Students (BASICS), which is the gold standard prevention and intervention approach to target heavy alcohol use on college campuses across the United States.

18 - 26 years of age All Phase N/A

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

Researchers are looking for new ways to treat advanced renal cell carcinoma (RCC). A standard (usual) treatment for certain people with RCC is belzutifan (a study medicine), which is a targeted therapy. Targeted therapy is a treatment that works to control how specific types of cancer cells grow and spread. …

18 years of age All Phase 3

Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery

The implementation of the AI-assisted radiology summary tool into clinical workflows is being conducted as part of a standard-of-care quality improvement (QI) initiative at UW Health. The evaluation of this tool's impact via structured feedback from patients and providers is being undertaken as a prospective research study.

18 years of age All Phase N/A

Simplify language using AI